Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer-Reference-Cited by-同舟云学术

Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer

Published:2013-02-18 Issue:8 Volume:111 Page:1269-1280
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Dahut William L.¹,Madan Ravi A.¹,Karakunnel Joyson J.¹,Adelberg David¹,Gulley James L.¹,Turkbey Ismail B.²,Chau Cindy H.¹,Spencer Shawn D.³,Mulquin Marcia¹,Wright John⁴,Parnes Howard L.⁵,Steinberg Seth M.⁶,Choyke Peter L.²,Figg William D.¹

Affiliation:

1. Medical Oncology Branch; Center for Cancer Research; National Cancer Institute; Bethesda; MD; USA

2. Molecular Imaging Program; Center for Cancer Research; National Cancer Institute; Bethesda; MD; USA

3. Clinical Pharmacology Program; SAIC-Frederick, Inc.; National Cancer Institute-Frederick; Bethesda; MD; USA

4. Cancer Therapy Evaluation Program; Division of Cancer Treatment and Diagnosis; National Cancer Institute; Bethesda; MD; USA

5. Division of Cancer Prevention; National Cancer Institute; Bethesda; MD; USA

6. Biostatistics and Data Management Section; Center for Cancer Research; National Cancer Institute; National Institutes of Health; Bethesda; MD; USA

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2012.11667.x/fullpdf

Reference37 articles.

1. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

2. Role of angiogenesis in the progression and treatment of prostate cancer;Choy;Cancer Invest,2001

3. Inhibition of angiogenesis: treatment options for patients with metastatic prostate cancer;Figg;Invest New Drugs,2002

4. Antiangiogenesis therapeutic strategies in prostate cancer;Macpherson;Cancer Metastasis Rev,2002

5. Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells;Ferrer;J Urol,1997

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pro-inflammatory cytokines and CXC chemokines as game-changer in age-associated prostate cancer and ovarian cancer: Insights from preclinical and clinical studies' outcomes;Pharmacological Research;2024-06

2. Therapeutic biomarkers in metastatic castration-resistant prostate cancer: does the state matter?;Critical Reviews in Clinical Laboratory Sciences;2023-10-26

3. Targeting Protein Kinases and Epigenetic Control as Combinatorial Therapy Options for Advanced Prostate Cancer Treatment;Pharmaceutics;2022-02-25

4. Phase I study of cediranib, an oral VEGFR inhibitor, in combination with selumetinib, an oral MEK inhibitor, in patients with advanced solid malignancies;Investigational New Drugs;2021-09-13

5. Protein kinase inhibitors for the treatment of prostate cancer;Expert Opinion on Pharmacotherapy;2021-05-14